GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AusCann Group Holdings Ltd (ASX:AC8) » Definitions » 1-Year ROIIC %

AusCann Group Holdings (ASX:AC8) 1-Year ROIIC % : -29.61% (As of Dec. 2023)


View and export this data going back to 1986. Start your Free Trial

What is AusCann Group Holdings 1-Year ROIIC %?

1-Year Return on Invested Incremental Capital (1-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 1-year. AusCann Group Holdings's 1-Year ROIIC % for the quarter that ended in Dec. 2023 was -29.61%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for AusCann Group Holdings's 1-Year ROIIC % or its related term are showing as below:

ASX:AC8's 1-Year ROIIC % is ranked worse than
70.82% of 898 companies
in the Drug Manufacturers industry
Industry Median: 0.28 vs ASX:AC8: -29.61

AusCann Group Holdings 1-Year ROIIC % Historical Data

The historical data trend for AusCann Group Holdings's 1-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AusCann Group Holdings 1-Year ROIIC % Chart

AusCann Group Holdings Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
1-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.96 -11.98 -19.88 -23.48 -166.81

AusCann Group Holdings Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
1-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.41 -23.48 -41.55 -166.81 -29.61

Competitive Comparison of AusCann Group Holdings's 1-Year ROIIC %

For the Drug Manufacturers - Specialty & Generic subindustry, AusCann Group Holdings's 1-Year ROIIC %, along with its competitors' market caps and 1-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AusCann Group Holdings's 1-Year ROIIC % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AusCann Group Holdings's 1-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where AusCann Group Holdings's 1-Year ROIIC % falls into.



AusCann Group Holdings 1-Year ROIIC % Calculation

AusCann Group Holdings's 1-Year ROIIC % for the quarter that ended in Dec. 2023 is calculated as:

1-Year ROIIC %=1-Year Incremental Net Operating Profit After Taxes (NOPAT)**/1-Year Incremental Invested Capital
=( -1.1912 (Dec. 2023) - -4.997 (Dec. 2022) )/( 3.489 (Dec. 2023) - 16.341 (Dec. 2022) )
=3.8058/-12.852
=-29.61%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** TTM data of NOPAT and Invested Capital was used to calculate 1-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


AusCann Group Holdings  (ASX:AC8) 1-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


AusCann Group Holdings 1-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of AusCann Group Holdings's 1-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


AusCann Group Holdings (ASX:AC8) Business Description

Traded in Other Exchanges
Address
35 Havelock Street, Level 5, West Perth, Perth, WA, AUS, 6005
AusCann Group Holdings Ltd produces medicinal cannabis. It delivers high-quality, economical, and clinically validated cannabinoid medicinal products.

AusCann Group Holdings (ASX:AC8) Headlines

No Headlines